Altered Maternal Acid–Base Adaptation During Complex Pregnancy-Associated Illness

Abstract

Pregnancy induces significant physiological changes in maternal acid–base homeostasis, primarily facilitating optimal fetal development. However, superimposed complex pregnancy-associated illnesses—including preeclampsia, sepsis, and acute respiratory distress—can disrupt these adaptations, resulting in profound clinical consequences. This review synthesizes recent evidence on the mechanisms, epidemiology, clinical features, diagnostic approaches, and management strategies of altered maternal acid–base balance in the context of complex pregnancy-associated illness, with a focus on guideline-based and emerging therapeutic interventions. The article aims to equip clinicians with actionable insights for early identification, risk stratification, and optimal care of affected patients.

Introduction

Pregnancy is an intricate physiological state characterized by extensive adaptations in maternal respiratory and metabolic processes. These adaptations ensure effective gas exchange, acid–base buffering, and nutrient supply for fetal growth. In healthy pregnancies, mild respiratory alkalosis due to hyperventilation is a well-recognized finding, with compensatory renal bicarbonate excretion stabilizing maternal pH. However, the onset of complex pregnancy-associated illnesses—such as hypertensive disorders, severe infections, and multi-organ dysfunction—can disrupt this delicate balance, leading to significant acid–base disturbances. Understanding the underlying mechanisms, clinical presentation, and management of altered maternal acid–base adaptation is critical for optimizing maternal-fetal outcomes in these high-risk scenarios.

Epidemiology / Disease Burden

Acid–base disturbances in pregnancy occur with increased frequency in the setting of complex co-morbid illnesses. Among critically ill obstetric patients, the prevalence of metabolic acidosis may range from 10% to 30%, particularly in those with preeclampsia, sepsis, diabetic ketoacidosis, or acute renal impairment. Respiratory alkalosis is almost universal in late gestation, but severe respiratory acidosis or mixed disturbances may develop during conditions such as acute pulmonary edema, pneumonia, or severe asthma. The burden of acid–base derangements is higher in resource-limited settings, correlating with increased rates of maternal morbidity, preterm birth, and perinatal mortality. Early recognition and intervention remain essential for mitigating adverse outcomes.

Pathophysiology

Normal pregnancy is marked by a compensatory respiratory alkalosis driven by progesterone-mediated hyperventilation, resulting in a decreased arterial pCO₂ (typically 28–32 mmHg) and a modest reduction in serum bicarbonate (18–22 mEq/L) due to renal compensation. In the setting of complex illness, several mechanisms can further disrupt acid–base equilibrium. Preeclampsia with renal impairment may reduce bicarbonate reabsorption, precipitating metabolic acidosis. Sepsis leads to lactic acidosis due to tissue hypoperfusion and anaerobic metabolism. Diabetic ketoacidosis (DKA)—more common in pregnant women with type 1 diabetes—results in high anion gap metabolic acidosis. Acute respiratory failure, as seen in pneumonia or ARDS, compromises CO₂ excretion, producing respiratory acidosis that is poorly tolerated by both mother and fetus. The fetal-placental unit is exquisitely sensitive to maternal acid–base status, with disturbances contributing to altered uteroplacental blood flow and fetal distress.

Risk Factors

Several maternal and pregnancy-specific factors predispose to altered acid–base adaptation in complex illness. Key risk factors include pre-existing renal or pulmonary disease, poorly controlled diabetes, multiple gestation, advanced maternal age, obesity, and a history of hypertensive disorders. Acute infections, such as pyelonephritis or sepsis, and exposure to nephrotoxic medications further increase risk. Iatrogenic factors—such as excessive intravenous fluid administration, inappropriate oxygen therapy, or delayed recognition of decompensation—also contribute. Identification of at-risk populations is vital for anticipatory monitoring and early therapeutic intervention.

Clinical Features

Clinical manifestations of altered acid–base adaptation are often non-specific and may overlap with normal pregnancy symptoms. However, severe disturbances may present with dyspnea, tachypnea, confusion, lethargy, and—if left uncorrected—progress to cardiovascular collapse or multi-organ failure. In metabolic acidosis, patients may exhibit Kussmaul respiration, hypotension, and, in DKA, characteristic fruity breath odor. Respiratory acidosis can present with hypoventilation, cyanosis, and altered consciousness. Fetal compromise may be indicated by decreased fetal movements, abnormal fetal heart rate tracing, or evidence of fetal acidosis on umbilical cord blood analysis. Close clinical monitoring and high suspicion are warranted in high-risk settings.

Diagnosis

Accurate diagnosis relies on thorough clinical assessment and timely laboratory evaluation. Arterial blood gas (ABG) analysis is the gold standard for assessing maternal acid–base status, revealing primary disturbances and compensatory responses. Serum electrolytes, lactate, glucose, and renal function tests provide additional diagnostic information. Urinalysis may reveal ketonuria in DKA or proteinuria in preeclampsia. Fetal surveillance—including non-stress testing and biophysical profile—assists in monitoring fetal well-being in the context of maternal acid–base derangement. Diagnostic algorithms should incorporate clinical context, laboratory data, and dynamic monitoring to guide intervention.

Treatment & Management

Management strategies must address both the underlying illness and the specific acid–base disturbance. In metabolic acidosis, prompt correction of precipitating factors—such as infection control in sepsis, insulin and fluid therapy in DKA, or renal support in acute kidney injury—is critical. Sodium bicarbonate therapy is reserved for severe acidosis (pH <7.1) or life-threatening situations. Respiratory acidosis requires optimization of airway, breathing, and oxygenation; mechanical ventilation may be indicated for refractory cases. Supportive care includes meticulous fluid management, avoidance of nephrotoxic drugs, and monitoring of maternal-fetal status. Multidisciplinary collaboration between obstetricians, intensivists, and neonatologists is essential for comprehensive care.

Recent Advances / Emerging Therapies

Recent research has focused on individualized management protocols, point-of-care ABG monitoring, and non-invasive fetal assessment techniques. Emerging therapies include the use of extracorporeal membrane oxygenation (ECMO) in refractory respiratory failure and novel renal replacement modalities in acute kidney injury during pregnancy. Advances in sepsis management—such as early goal-directed therapy and lactate-guided resuscitation—have shown promise in improving outcomes. Ongoing studies are exploring the role of targeted metabolic modulators and precision medicine approaches in optimizing acid–base homeostasis in complex pregnancy-associated illnesses.

Guideline Recommendations

Current guidelines from leading authorities—including the American College of Obstetricians and Gynecologists (ACOG), Society of Critical Care Medicine (SCCM), and Royal College of Obstetricians and Gynaecologists (RCOG)—emphasize the importance of early identification, multidisciplinary management, and individualized therapy for acid–base disturbances in pregnancy. Key recommendations include routine acid–base monitoring in high-risk patients, judicious use of bicarbonate therapy, and prioritization of maternal stabilization before delivery in cases of severe illness. Fetal monitoring and decision-making regarding timing of delivery should be guided by combined maternal and fetal status.

Conclusion

Altered maternal acid–base adaptation during complex pregnancy-associated illness represents a significant clinical challenge with potential for severe maternal and fetal morbidity. A thorough understanding of the underlying mechanisms, risk factors, and evidence-based management strategies is essential for optimizing outcomes. Advances in diagnostic modalities and emerging therapies hold promise for improving care in this vulnerable population. Continued research and adherence to multidisciplinary, guideline-driven protocols will be critical in addressing this important aspect of maternal-fetal medicine.